Clinical Trial Update: Aspirin Non-responsiveness and Clopidogrel Endpoint Trial. [Phase 4]

View source ↗

Summary

This Phase 4 trial evaluating aspirin non-responsiveness and a clopidogrel endpoint has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Atherosclerosis
• Coronary Heart Disease

Drugs mentioned

• Aspirin (Aspirin)
• Plavix (clopidogrel)

Snippet

Sponsor: Ullevaal University Hospital | Conditions: Coronary Heart Disease, Angina Pectoris | Phase 4 | Status: COMPLETED